Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

Copper-doxorubicin nanoparticles effectively treat tumors with less toxicity.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Tumor-targeted drug carriers can improve chemotherapy precision and reduce side effects.

Cyclophosphamide can cause serious short-term and long-term side effects, including increased cancer risk and infertility.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Natural honey protects against Doxorubicin's harmful effects.

Targeted cancer therapies often cause serious skin problems that need careful management.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

The compound 4c showed strong potential as an anticancer agent.

Some herbal medicines can interfere with chemotherapy, affecting treatment and causing side effects.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Mononuclear cells may protect against certain chemotherapy-induced hair loss.

Mannitol diuresis allows higher doses of cis-platinum for testicular cancer treatment without increasing kidney damage.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Doxil is an effective, modified chemotherapy drug with a unique toxicity profile and shows promise in treating certain cancers.

Chemotherapy drugs can cause abnormal growth and changes in healthy skin and gland cells.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Using ultrasound may make cisplatin more effective against cervical cancer in mice.